The Biosimilars Market size was valued at USD 29.51 Billion in 2023 and is expected to reach USD 108.8 Billion By 2031 and grow at a CAGR of 17.7% over the forecast period of 2024-2031.The biosimilars market represents a dynamic frontier in healthcare, characterized by its rapid evolution and transformative impact on global access to biologic therapies. As innovator biologics face patent...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian